uric acid has been researched along with Scleroderma, Systemic in 14 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Uric acid (UA) has been shown to be elevated in patients with pulmonary hypertension (PH) and heart failure." | 7.77 | Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. ( Dimitroula, H; Dimitroulas, T; Giannakoulas, G; Karvounis, H; Parcharidou, D; Settas, L; Sfetsios, T, 2011) |
| "Urea clearances were not significantly different from usual values." | 5.26 | Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol. ( Hirszel, P; Husted, FC; Miller, L; Nolph, KD, 1976) |
| " Uric acid (UA) has been shown to be elevated in patients with pulmonary hypertension (PH) and heart failure." | 3.77 | Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. ( Dimitroula, H; Dimitroulas, T; Giannakoulas, G; Karvounis, H; Parcharidou, D; Settas, L; Sfetsios, T, 2011) |
| "Urea clearances were not significantly different from usual values." | 1.26 | Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol. ( Hirszel, P; Husted, FC; Miller, L; Nolph, KD, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Drosos, GC | 1 |
| Vedder, D | 1 |
| Houben, E | 1 |
| Boekel, L | 1 |
| Atzeni, F | 1 |
| Badreh, S | 1 |
| Boumpas, DT | 1 |
| Brodin, N | 1 |
| Bruce, IN | 1 |
| González-Gay, MÁ | 1 |
| Jacobsen, S | 1 |
| Kerekes, G | 1 |
| Marchiori, F | 1 |
| Mukhtyar, C | 1 |
| Ramos-Casals, M | 1 |
| Sattar, N | 1 |
| Schreiber, K | 1 |
| Sciascia, S | 1 |
| Svenungsson, E | 1 |
| Szekanecz, Z | 1 |
| Tausche, AK | 1 |
| Tyndall, A | 1 |
| van Halm, V | 1 |
| Voskuyl, A | 1 |
| Macfarlane, GJ | 1 |
| Ward, MM | 1 |
| Nurmohamed, MT | 1 |
| Tektonidou, MG | 1 |
| Sredojevic, SI | 1 |
| Dolijanovic, SP | 1 |
| Dozic, I | 1 |
| Pficer, JK | 1 |
| Aleksic, Z | 1 |
| Nikolic-Jakoba, NS | 1 |
| Kim, E | 1 |
| Lee, HN | 1 |
| Kim, YK | 1 |
| Kim, GT | 1 |
| So, MW | 1 |
| Ahn, E | 1 |
| Sohn, DH | 1 |
| Lee, SG | 1 |
| Zalewska, A | 1 |
| Knaś, M | 1 |
| Gińdzieńska-Sieśkiewicz, E | 1 |
| Waszkiewicz, N | 1 |
| Klimiuk, A | 1 |
| Litwin, K | 1 |
| Sierakowski, S | 1 |
| Waszkiel, D | 1 |
| Rich, JD | 1 |
| Rich, S | 1 |
| Gigante, A | 1 |
| Barbano, B | 1 |
| Barilaro, G | 1 |
| Quarta, S | 1 |
| Gasperini, ML | 1 |
| Di Mario, F | 1 |
| Romaniello, A | 1 |
| Amoroso, A | 1 |
| Cianci, R | 1 |
| Rosato, E | 1 |
| Dimitroulas, T | 1 |
| Giannakoulas, G | 1 |
| Dimitroula, H | 1 |
| Sfetsios, T | 1 |
| Parcharidou, D | 1 |
| Karvounis, H | 1 |
| Settas, L | 1 |
| BARCELO, P | 1 |
| SANSSOLA, YL | 1 |
| de Groot, K | 1 |
| Akizuki, M | 1 |
| Yoshida, S | 1 |
| Jacobs, RP | 1 |
| Nolph, KD | 1 |
| Miller, L | 1 |
| Husted, FC | 1 |
| Hirszel, P | 1 |
| Leroy, EC | 1 |
| Kagen, LJ | 1 |
| Kaplan, D | 1 |
| Lightfoot, RW | 1 |
| Sandson, J | 1 |
| Wallace, SL | 1 |
| Ferguson, RH | 1 |
| Worthington, JW | 1 |
4 reviews available for uric acid and Scleroderma, Systemic
| Article | Year |
|---|---|
Clinical diagnosis of pulmonary hypertension.
Topics: Age Distribution; Age of Onset; Cardiac Catheterization; Diagnostic Techniques, Cardiovascular; Elec | 2014 |
[Kidneys in rheumatic diseases].
Topics: Animals; Anti-Inflammatory Agents; Antigen-Antibody Complex; Arteritis; Gout; Humans; Immune Complex | 1983 |
The 1968 interim scientific session of the American Rheumatism Association.
Topics: Amyloidosis; Arthritis, Rheumatoid; Collagen Diseases; Fibroblasts; gamma-Globulins; Gout; Humans; L | 1969 |
Recent advances in rheumatic diseases: 1967 through 1969.
Topics: Arthritis; Arthritis, Infectious; Arthritis, Reactive; Arthritis, Rheumatoid; Behcet Syndrome; Colla | 1970 |
10 other studies available for uric acid and Scleroderma, Systemic
| Article | Year |
|---|---|
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Cardiovascular Diseases; Gout; Heart Disease Risk Factors; Humans; Lupus | 2022 |
Salivary Antioxidant Profile in Patients with Systemic Sclerosis and Periodontitis.
Topics: Chronic Periodontitis; Humans; Oxidoreductases; Saliva; Scleroderma, Systemic; Superoxide Dismutase; | 2023 |
Increased serum uric acid levels are associated with digital ulcers in patients with systemic sclerosis.
Topics: Adult; C-Reactive Protein; Cross-Sectional Studies; Fingers; Glomerular Filtration Rate; Humans; Log | 2019 |
Salivary antioxidants in patients with systemic sclerosis.
Topics: Adult; Aged; Antioxidants; Atrophy; Case-Control Studies; Colorimetry; DMF Index; Female; Fibrosis; | 2014 |
Serum uric acid as a marker of microvascular damage in systemic sclerosis patients.
Topics: Adult; Arterial Pressure; Biomarkers; Creatinine; Echocardiography; Female; Humans; Male; Microcircu | 2016 |
Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.
Topics: Aged; Exercise; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pilot Projects; Pulmonar | 2011 |
[LIVER CATALASE IN THE TREATMENT OF GOUT AND OTHER RHEUMATIC DISEASES].
Topics: Biomedical Research; Catalase; Cholesterol; Dermatomyositis; Drug Therapy; Gout; Liver; Porphyrias; | 1964 |
[Renal manifestations in rheumatic diseases].
Topics: Amyloidosis; Diagnosis, Differential; Glomerulonephritis, IGA; Glomerulonephritis, Membranoprolifera | 2007 |
Drug-induced rheumatic diseases.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antineoplastic Agents; Diuretics; Gout; Heparin; Humans; H | 1984 |
Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.
Topics: Adult; Cell Membrane Permeability; Creatinine; Diabetes Mellitus; Female; Humans; Isoproterenol; Mid | 1976 |